“Increased Plasma Caspase-3 in Children with Down Syndrome is Associated with an Increasing Risk of Pulmonary Hypertension” (2023) Journal of Maternal and Child Health, 8(1), pp. 23–32. doi:10.26911/thejmch.2023.08.01.03.